Anesthesia management in pediatric bronchoscopy
Surgery on Children · 2024
DOI: 10.51271/soc-0021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery on Children, 2024. Verfasst von Akif Demirel und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The primary aim of this retrospective study is to analyze pediatric bronchoscopy cases performed under general anesthesia, evaluating the indications, findings, and adverse events.
Methods
The study included a total of 31 pediatric patients who underwent rigid and flexible bronchoscopy under general anesthesia at Bozok University Faculty of Medicine Hospital between July 1, 2018, and May 1, 2024. Demographic data, types of anesthesia, anesthetic agents, and length of hospital stay were recorded. Anesthesia management and surgical processes were described in detail.
Results
The study found that an increased duration of bronchoscopy was associated with a higher likelihood of laryngospasm and bronchospasm (p=0.049). Additionally, in line with the literature, the average age of patients included in our study who underwent bronchoscopy for diagnostic and therapeutic purposes was determined to be 33 months. The incidence of laryngospasm and bronchospasm was found to be 16.1%, which is consistent with other studies in the literature.
Conclusion
Our study indicates that foreign body aspiration occurs most commonly in male children under three years of age and that prolonged bronchoscopy durations increase the risk of laryngospasm and bronchospasm.
Zitieren
APA
Demirel, A., Yardımcı, C., & Polat, M. N. (2024). Anesthesia management in pediatric bronchoscopy. Surgery on Children. https://doi.org/10.51271/soc-0021
Vancouver
Demirel A, Yardımcı C, Polat MN. Anesthesia management in pediatric bronchoscopy. Surgery on Children. 2024. doi:10.51271/soc-0021
BibTeX
@article{Demirel2024,
author = {Demirel, Akif and Yardımcı, Cevdet and Polat, Muhammed Nuri},
title = {Anesthesia management in pediatric bronchoscopy},
journal = {Surgery on Children},
year = {2024},
doi = {10.51271/soc-0021}
}
EUVIMED